Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment
Clinical trial NCT07422610 · RECRUITING
Trial details
- NCT number
- NCT07422610
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-24
- Primary completion
- 2028-06-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.